» Articles » PMID: 36115905

Cancer Stem Cells Induced by Chronic Stimulation with Prostaglandin E2 Exhibited Constitutively Activated PI3K Axis

Overview
Journal Sci Rep
Specialty Science
Date 2022 Sep 17
PMID 36115905
Authors
Affiliations
Soon will be listed here.
Abstract

Previously, our group has demonstrated establishment of Cancer Stem Cell (CSC) models from stem cells in the presence of conditioned medium of cancer cell lines. In this study, we tried to identify the factors responsible for the induction of CSCs. Since we found the lipid composition could be traced to arachidonic acid cascade in the CSC model, we assessed prostaglandin E2 (PGE2) as a candidate for the ability to induce CSCs from induced pluripotent stem cells (iPSCs). Mouse iPSCs acquired the characteristics of CSCs in the presence of 10 ng/mL of PGE2 after 4 weeks. Since constitutive Akt activation and pik3cg overexpression were found in the resultant CSCs, of which growth was found independent of PGE2, chronic stimulation of the receptors EP-2/4 by PGE2 was supposed to induce CSCs from iPSCs through epigenetic effect. The bioinformatics analysis of the next generation sequence data of the obtained CSCs proposed not only receptor tyrosine kinase activation by growth factors but also extracellular matrix and focal adhesion enhanced PI3K pathway. Collectively, chronic stimulation of stem cells with PGE2 was implied responsible for cancer initiation enhancing PI3K/Akt axis.

Citing Articles

Unveiling the omics tapestry of B-acute lymphoblastic leukemia: bridging genomics, metabolomics, and immunomics.

Le Y, Zhu S, Peng H, Wang Z Sci Rep. 2025; 15(1):3188.

PMID: 39863799 PMC: 11762316. DOI: 10.1038/s41598-025-87684-3.


A Landscape of Cancer Initiation and Cancer Stem Cells.

Seno M Cancers (Basel). 2025; 17(2).

PMID: 39857984 PMC: 11764454. DOI: 10.3390/cancers17020203.


Cancer stem cells: advances in knowledge and implications for cancer therapy.

Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z Signal Transduct Target Ther. 2024; 9(1):170.

PMID: 38965243 PMC: 11224386. DOI: 10.1038/s41392-024-01851-y.


Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies.

Wang K, Wang Y, Yin K J Cancer Res Clin Oncol. 2024; 150(5):243.

PMID: 38717677 PMC: 11078801. DOI: 10.1007/s00432-024-05755-w.


Interconversion of Cancer Cells and Induced Pluripotent Stem Cells.

Sarker D, Xue Y, Mahmud F, Jocelyn J, Sang Q Cells. 2024; 13(2).

PMID: 38247819 PMC: 10814385. DOI: 10.3390/cells13020125.


References
1.
Afify S, Seno M . Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation. Cancers (Basel). 2019; 11(3). PMC: 6468812. DOI: 10.3390/cancers11030345. View

2.
Hu Y, Smyth G . ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009; 347(1-2):70-8. DOI: 10.1016/j.jim.2009.06.008. View

3.
BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

4.
Ioris R, Galie M, Ramadori G, Anderson J, Charollais A, Konstantinidou G . SIRT6 Suppresses Cancer Stem-like Capacity in Tumors with PI3K Activation Independently of Its Deacetylase Activity. Cell Rep. 2017; 18(8):1858-1868. PMC: 5329120. DOI: 10.1016/j.celrep.2017.01.065. View

5.
Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View